deferoxamine has been researched along with ferrous sulfate in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (28.07) | 18.7374 |
| 1990's | 17 (29.82) | 18.2507 |
| 2000's | 16 (28.07) | 29.6817 |
| 2010's | 7 (12.28) | 24.3611 |
| 2020's | 1 (1.75) | 2.80 |
| Authors | Studies |
|---|---|
| Goldman, LS; Goyert, GL; Lacoste, H; Schwartz, DB; Wright, DJ | 1 |
| Durbin, DR; Wood, BP | 1 |
| Bertaccini, EJ; Everson, GW; O'Leary, J | 1 |
| Aitken, RJ; Johnson, MH; Nasr-Esfahani, M | 1 |
| Harrington, JA; Porter, DJ; Spector, T | 1 |
| Hallaway, PE; Hedlund, BE; Mahoney, JR | 1 |
| Baysal, E; Jones, JG; Jones, SA; Rice-Evans, C; Singh, S | 1 |
| Cantanna, R; Morini, M | 1 |
| Chevion, M; Kohen, R | 1 |
| Pelteret, RM | 1 |
| Biber, B; Dottori, O; Olenmark, M; Rybo, G | 1 |
| Smith, CV | 1 |
| Klein, M; Reynolds, LG | 1 |
| Bonkovsky, HL; Healey, JF; Sinclair, JF; Sinclair, PR | 1 |
| Henretig, FM; Temple, AR | 1 |
| Donn, SM; Rayburn, WF; Wulf, ME | 1 |
| Cabbat, FS; Heikkila, RE | 1 |
| Odumosu, A | 1 |
| Peck, MG; Rivenbark, JF; Rogers, JF | 1 |
| Choi, YC; Hough, AJ; Morris, GM; Sokoloff, L | 1 |
| Khoury, S; Odeh, M; Oettinger, M | 1 |
| Günther, T; Höllriegl, V; Vormann, J | 1 |
| Hider, RC; Lamb, DJ; Leake, DS | 1 |
| Aitken, RJ; Buckingham, DW; Harkiss, D | 1 |
| Deshpande, D; Liang, WW; Rojanasakul, Y; Shi, X; Wang, LY | 1 |
| Dean, BS; Griffith, GR; Hines, RH; Krenzelok, EP; Oehme, FW | 1 |
| Brooks, A; Cox, GW; Melillo, G; Musso, T; Taylor, LS; Varesio, L | 1 |
| Brent, J; Dart, RC; Flory, D; Gomez, HF; McClafferty, HH | 1 |
| Banner, W | 1 |
| Bout, DT; Dimier, IH | 1 |
| Boroujeni, HM; Habibzadeh, F; Sajedianfard, J | 1 |
| Kim, JE; Sheen, YY | 1 |
| Anderson, D; Chua-Anusorn, W; Cole, C; Vives-Bauza, C; Webb, J; Yardley-Jones, A | 1 |
| Higo, A; Katsura, M; Mohri, Y; Ohkuma, S; Shirotani, K; Shuto, K; Takesue, M; Tarumi, C | 1 |
| Ali, AM; Dai, J; Fournier, J; Frenkel, K; Huang, X; Zhang, Q | 1 |
| Bosco, MC; Melillo, G; Negrioli, A; Pastorino, S; Rapella, A; Varesio, L | 1 |
| Vaughan, JE; Walsh, SW | 1 |
| MACK, RB; MCENERY, JT | 1 |
| GOODWIN, JF; WHITTEN, CF | 1 |
| Alldredge, CD; Levin, LA; Miller, NR; Schlieve, CR | 1 |
| Cameron, RE; Hicks, J; Johnson, AF; Khunkamchoo, P; Laity, PR; Norris, K; Taylor, JE; Wong, SS | 1 |
| Almazan, G; Hemdan, S | 1 |
| Huang, XJ; Lu, YB; Ma, ZQ; Wei, EQ; Zhang, WP | 1 |
| Clarke, SE; Hollis, FJ; Maggs, JL; Naisbitt, DJ; Park, BK; Sanderson, JP | 1 |
| Bagherpour, B; Gharagozloo, M; Moayedi, B | 1 |
| Hao, L; Lehmann, A; Liu, L; Neuhaus, P; Nussler, A; Nussler, N; Song, F; Yao, P; Zhao, J | 1 |
| Anderson, GJ; Deng, X; Ishikawa, H; Khomenko, T; McLaren, GD; Szabo, S | 1 |
| Mastropietro, C; Sarnaik, AP; Valentine, K | 1 |
| Hassan, W; Ibrahim, M; Rocha, JB | 1 |
| Garcia, AJ; Khan, SA; Kumar, GK; Prabhakar, NR; Ramirez, JM | 1 |
| Leake, DS; Satchell, L | 1 |
| Ermens, AA; Simonse, E; Valk-Swinkels, CG; van 't Veer, NE; Veldkamp, EJ | 1 |
| Chang, Q; Jia, W; Jiang, H; Sun, P; Xie, J; Xu, H | 1 |
| Castro, P; Fernández, S; Nicolás, JM; Nogué, S | 1 |
| Qiao, C; Wang, L; Xiao, SH; Xue, J | 1 |
| Choi, SE; Han, SJ; Jung, IR; Jung, JG; Kang, Y; Kim, DJ; Kim, HJ; Lee, KW; Lee, SA | 1 |
| Degrassi, S; Fusi-Schmidhauser, T; Pietra, V | 1 |
1 review(s) available for deferoxamine and ferrous sulfate
| Article | Year |
|---|---|
Acute iron intoxication in pregnancy: case report and review of the literature.
Topics: Adolescent; Deferoxamine; Delayed-Action Preparations; Female; Ferrous Compounds; Humans; Poisoning; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Suicide, Attempted | 1992 |
1 trial(s) available for deferoxamine and ferrous sulfate
| Article | Year |
|---|---|
Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
Topics: Administration, Oral; Adult; Antidotes; Area Under Curve; Charcoal; Cross-Over Studies; Deferoxamine; Female; Ferrous Compounds; Humans; Intestinal Absorption; Iron; Iron Chelating Agents; Male; Poisoning; Prospective Studies | 1997 |
55 other study(ies) available for deferoxamine and ferrous sulfate
| Article | Year |
|---|---|
Radiological case of the month. Acute iron poisoning and gastrointestinal decontamination procedure.
Topics: Deferoxamine; Diagnosis, Differential; Ferrous Compounds; Fluid Therapy; Gastric Lavage; Humans; Infant; Infusions, Intravenous; Male; Poisoning; Polyethylene Glycols; Radiography | 1992 |
Use of whole bowel irrigation in an infant following iron overdose.
Topics: Deferoxamine; Ferrous Compounds; Humans; Infant; Intestine, Large; Ipecac; Male; Poisoning; Therapeutic Irrigation | 1991 |
The effect of iron and iron chelators on the in-vitro block to development of the mouse preimplantation embryo: BAT6 a new medium for improved culture of mouse embryos in vitro.
Topics: Animals; Apoproteins; Ascorbic Acid; Cell Division; Culture Media; Culture Techniques; Deferoxamine; Dose-Response Relationship, Drug; Edetic Acid; Embryo, Mammalian; Embryonic Development; Female; Ferrous Compounds; Iron; Iron Chelating Agents; Mice; Pentetic Acid; Pregnancy; Transferrin | 1990 |
Herpes simplex virus type 1 ribonucleotide reductase: selective and synergistic inactivation by A1110U and its iron complex.
Topics: Adenosine Triphosphate; Cytidine Diphosphate; Deferoxamine; Drug Synergism; Enzyme Activation; Enzyme Reactivators; Ferrous Compounds; Humans; Hydrazones; Iron; Iron Chelating Agents; Kinetics; Magnesium Chloride; Molecular Structure; Oxidation-Reduction; Phenanthrolines; Pyridines; Ribonucleotide Reductases; Simplexvirus | 1990 |
High molecular weight forms of deferoxamine: novel therapeutic agents for treatment of iron-mediated tissue injury.
Topics: Animals; Deferoxamine; Ferrous Compounds; Iron; Lethal Dose 50; Male; Mice; Models, Biological; Molecular Weight | 1990 |
The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes.
Topics: Ascorbic Acid; Biological Transport; Cell Membrane Permeability; Chelating Agents; Deferoxamine; Erythrocyte Membrane; Ferrous Compounds; Hemoglobins; Humans; Hydrogen Peroxide; Hydroxylation; Oxidation-Reduction; Pyridones | 1989 |
[Respiratory distress syndrome in a case of ferrous sulfate poisoning].
Topics: Child, Preschool; Deferoxamine; Female; Ferrous Compounds; Humans; Radiography; Respiratory Insufficiency | 1988 |
Cytoplasmic membrane is the target organelle for transition metal mediated damage induced by paraquat in Escherichia coli.
Topics: Adenosine Triphosphate; Catalase; Cell Membrane; Copper; Copper Sulfate; Deferoxamine; Enzyme Induction; Escherichia coli; Ferrous Compounds; Leucine; Microscopy, Electron; Paraquat; Potassium | 1988 |
Iron poisoning, chelation therapy and anaemia.
Topics: Anemia, Hypochromic; Child, Preschool; Deferoxamine; Ferrous Compounds; Humans; Iron Chelating Agents; Male | 1988 |
Fatal iron intoxication in late pregnancy.
Topics: Adult; Cesarean Section; Deferoxamine; Delayed-Action Preparations; Female; Ferrous Compounds; Humans; Infant, Newborn; Iron; Liver Function Tests; Pregnancy; Pregnancy Complications; Suicide | 1987 |
Evidence for participation of lipid peroxidation and iron in diquat-induced hepatic necrosis in vivo.
Topics: Animals; Chemical Phenomena; Chemistry; Deferoxamine; Diquat; Ethane; Ferrous Compounds; Glutathione; Glutathione Disulfide; Iron; Lipid Peroxides; Liver; Male; Necrosis; Oxidation-Reduction; Pentanes; Pyridinium Compounds; Rats; Rats, Inbred F344 | 1987 |
Iron poisoning--a preventable hazard of childhood.
Topics: Child, Preschool; Deferoxamine; Drug Packaging; Female; Ferrous Compounds; Gastric Lavage; Humans; Infant; Iron; Male; Mortality; South Africa | 1985 |
Conversion of 5-aminolaevulinate into haem by homogenates of human liver. Comparison with rat and chick-embryo liver homogenates.
Topics: Aminolevulinic Acid; Animals; Chick Embryo; Deferoxamine; Dithiothreitol; Ferrous Compounds; Heme; Humans; Kinetics; Levulinic Acids; Liver; Models, Biological; Porphobilinogen Synthase; Protoporphyrins; Rats; Rats, Inbred Strains | 1985 |
Acute iron poisoning in children.
Topics: Acute Disease; Animals; Cardiovascular Diseases; Central Nervous System Diseases; Child; Child, Preschool; Deferoxamine; Diagnosis, Differential; Emergencies; Ferrous Compounds; Gastric Lavage; Gastrointestinal Diseases; Humans; Infant; Ipecac; Iron; Prognosis; Risk; Time Factors; Triage | 1984 |
Iron overdose during pregnancy: successful therapy with deferoxamine.
Topics: Adult; Deferoxamine; Female; Ferrous Compounds; Humans; Iron; Pregnancy; Suicide, Attempted | 1983 |
Inhibition of iron-stimulated catecholamine degradation by the iron-chelators DETAPAC and Desferal. Potentially useful laboratory agents.
Topics: Catecholamines; Deferoxamine; Drug Stability; Edetic Acid; Ferrous Compounds; Iron Chelating Agents; Oxidation-Reduction; Pentetic Acid | 1981 |
Ascorbic acid and iron levels in plasma and liver of vitamin C deficient guinea pigs after iron overload and desferrioxamine administration.
Topics: Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Deferoxamine; Dose-Response Relationship, Drug; Female; Ferrous Compounds; Guinea Pigs; Iron; Liver | 1982 |
Use of high doses of deferoxamine (Desferal) in an adult patient with acute iron overdosage.
Topics: Adult; Child; Deferoxamine; Drug Administration Schedule; Female; Ferrous Compounds; Gastric Lavage; Humans; Infusions, Parenteral; Iron | 1982 |
Experimental siderosis of articular chondrocytes cultured in vitro.
Topics: Animals; Ascorbic Acid; Cartilage, Articular; Cattle; Cells, Cultured; Deferoxamine; Disease Models, Animal; Erythrocytes; Ferrous Compounds; Iron; Organ Culture Techniques; Phagocytes; Rabbits; Siderosis | 1981 |
Deferoxamine treatment for acute iron intoxication in pregnancy.
Topics: Adult; Antidotes; Deferoxamine; Female; Ferrous Compounds; Humans; Injections, Intravenous; Iron; Pregnancy; Pregnancy Complications; Self Administration | 1995 |
Effects of magnesium and iron on lipid peroxidation in cultured hepatocytes.
Topics: Animals; Ascorbic Acid; Cells, Cultured; Culture Media; Deferoxamine; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Ferrous Compounds; Free Radicals; Lipid Peroxidation; Liver; Magnesium; Malondialdehyde; Rats; Reactive Oxygen Species; Time Factors | 1995 |
Hydroxypyridinones and desferrioxamine inhibit macrophage-mediated LDL oxidation by iron but not by copper.
Topics: Animals; Copper; Copper Sulfate; Deferiprone; Deferoxamine; Ferrous Compounds; Humans; In Vitro Techniques; Iron Chelating Agents; Lipoproteins, LDL; Macrophages, Peritoneal; Mice; Pyridones | 1993 |
Analysis of lipid peroxidation mechanisms in human spermatozoa.
Topics: Deferoxamine; Edetic Acid; Ferrous Compounds; Humans; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Reactive Oxygen Species; Spectrophotometry; Spermatozoa; Thiobarbiturates | 1993 |
Protection against oxidative injury and permeability alteration in cultured alveolar epithelium by transferrin-catalase conjugate.
Topics: Animals; Catalase; Cells, Cultured; Deferoxamine; Electron Spin Resonance Spectroscopy; Endocytosis; Ferrous Compounds; Fluoresceins; Fluorescence; Hydrogen Peroxide; Male; Mannitol; Oxidative Stress; Permeability; Propidium; Protein Binding; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Specific Pathogen-Free Organisms; Spin Labels; Transferrin | 1996 |
Iron complexation with oral deferoxamine in a swine model.
Topics: Administration, Oral; Animals; Antidotes; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Overdose; Ferrous Compounds; Intestinal Absorption; Male; Poisoning; Reactive Oxygen Species; Swine | 1996 |
Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine.
Topics: Animals; Base Sequence; Cell Hypoxia; Cell Line; Cell Nucleus; Consensus Sequence; Deferoxamine; Enzyme Induction; Ferrous Compounds; Gene Expression Regulation, Enzymologic; Humans; Interferon-gamma; Macrophages; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Promoter Regions, Genetic; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Transfection | 1997 |
Of iron and ancient mariners.
Topics: Animals; Antidotes; Charcoal; Deferoxamine; Dogs; Ferrous Compounds; Humans; Iron; Poisoning | 1997 |
Interferon-gamma-activated primary enterocytes inhibit Toxoplasma gondii replication: a role for intracellular iron.
Topics: Animals; Cell Separation; Deferoxamine; Epithelial Cells; Female; Ferrous Compounds; Intestines; Intracellular Fluid; Iron; Male; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Rats; Rats, Wistar; Reactive Oxygen Species; Toxoplasma; Toxoplasmosis | 1998 |
Therapeutic values of different routes of administration of vitamin A with ferrous sulfate in treating deferoxamin-induced iron-deficiency anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Deferoxamine; Ferrous Compounds; Injections, Intramuscular; Injections, Intraperitoneal; Rats; Rats, Sprague-Dawley; Vitamin A | 1999 |
Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-stimulated Cyp1a1 promoter activity by hypoxic agents.
Topics: Animals; Antimutagenic Agents; Cell Hypoxia; Cells, Cultured; Chelating Agents; Cobalt; Cytochrome P-450 CYP1A1; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Ferrous Compounds; Gene Expression Regulation, Enzymologic; Genes, Reporter; Luciferases; Mice; Oxygen; Picolinic Acids; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Time Factors | 2000 |
Effect of iron salts, haemosiderins, and chelating agents on the lymphocytes of a thalassaemia patient without chelation therapy as measured in the comet assay.
Topics: Australia; beta-Thalassemia; Blood Transfusion; Chelating Agents; Chlorides; Comet Assay; Deferiprone; Deferoxamine; DNA Damage; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemosiderin; Humans; Lymphocytes; Male; Pyridones; Reference Values; Spleen | 2000 |
Suppression of Ca2+ influx through L-type voltage-dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Deferoxamine; Ferrous Compounds; Free Radical Scavengers; Hydrogen Peroxide; Hydroxyl Radical; Ion Channel Gating; Ion Transport; Iron Chelating Agents; Mannitol; Mice; Nerve Tissue Proteins; Neurons; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Potassium Chloride; Thiourea | 2001 |
Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells.
Topics: 2,2'-Dipyridyl; Carcinoma, Hepatocellular; Culture Media; Deferoxamine; Drug Combinations; Ferric Compounds; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Iron Overload; Lipid Peroxidation; Oxidants; Oxidation-Reduction; Oxygen; Tumor Cells, Cultured | 2002 |
Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma.
Topics: Antineoplastic Agents; Cell Hypoxia; Deferoxamine; Endothelial Growth Factors; Ferrous Compounds; Flavonoids; Gene Expression; Humans; Iron Chelating Agents; Lymphokines; Neuroblastoma; Picolinic Acids; Piperidines; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Oxidative stress reproduces placental abnormalities of preeclampsia.
Topics: Adult; Analysis of Variance; Catalase; Cell Line; Chorionic Gonadotropin; Deferoxamine; Female; Ferrous Compounds; Glutathione Peroxidase; Humans; Iron Chelating Agents; Linoleic Acid; Lipid Peroxidation; Oxidative Stress; Pre-Eclampsia; Pregnancy; Superoxide Dismutase; Thromboxane B2; Trophoblasts; Xanthine Oxidase | 2002 |
USE OF DESFERRIOXAMINE IN A CASE OF ACUTE FERROUS SULFATE POISONING.
Topics: Child; Deferoxamine; Drug Therapy; Ferrous Compounds; Heavy Metal Poisoning; Metals, Heavy; Poisoning; Sulfates; Toxicology | 1964 |
CHELATION OF FERROUS SULPHATE SOLUTIONS BY DESFERRIOXAMINE B.
Topics: Catalysis; Chelating Agents; Chemical Phenomena; Chemistry; Deferoxamine; Ferrous Compounds; Iron; Research; Solutions; Sulfates | 1965 |
Pathophysiology of the optic neuropathy associated with Friedreich ataxia.
Topics: Animals; Animals, Newborn; Anisoles; Cell Death; Cells, Cultured; Chlorides; Deferoxamine; Ferric Compounds; Ferrous Compounds; Fluorescent Dyes; Frataxin; Friedreich Ataxia; Iron Chelating Agents; Iron-Binding Proteins; Mitochondria; Optic Nerve Diseases; Oxidative Stress; Pyrones; Rats; Rats, Long-Evans; Reactive Oxygen Species; Retinal Ganglion Cells | 2003 |
Extent of iron pick-up in deforoxamine-coupled polyurethane materials for therapy of chronic wounds.
Topics: Adhesives; Bandages; Deferoxamine; Electron Probe Microanalysis; Ferrous Compounds; Hematinics; Imidazoles; Ions; Iron; Microscopy, Atomic Force; Microscopy, Electron; Microscopy, Energy-Filtering Transmission Electron; Models, Chemical; Oxidative Stress; Polyurethanes; Scattering, Radiation; Sulfur; Wound Healing; X-Rays | 2005 |
Iron contributes to dopamine-induced toxicity in oligodendrocyte progenitors.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Caspases; Cell Nucleus; Deferoxamine; Dopamine; Dopamine Agents; Enzyme Activation; Ferrous Compounds; Heme Oxygenase-1; Necrosis; Oligodendroglia; Rats; Rats, Sprague-Dawley; Siderophores; Stem Cells | 2006 |
Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Hypoxia; Cell Proliferation; Cell Survival; Cells, Cultured; Chelating Agents; Deferoxamine; Ferrous Compounds; Glioma; Hypoxia-Inducible Factor 1, alpha Subunit; Rats; Reactive Oxygen Species; Sesquiterpenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factors | 2007 |
Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites.
Topics: Ascorbic Acid; Chromatography, High Pressure Liquid; Deferoxamine; Edetic Acid; Enzyme Inhibitors; Ferrous Compounds; Humans; Hydrogen Peroxide; Hydroxylation; Kinetics; Microsomes, Liver; Molecular Structure; NADP; Sulfamethoxazole; Tandem Mass Spectrometry; Triazoles | 2008 |
The influence of iron loading and iron chelation on the proliferation and telomerase activity of human peripheral blood mononuclear cells.
Topics: Cell Proliferation; Deferoxamine; Ferrous Compounds; Hematinics; Humans; Iron; Iron Chelating Agents; Leukocytes, Mononuclear; Lymphocytes; Phytohemagglutinins; Silymarin; Telomerase | 2009 |
The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage.
Topics: Allyl Compounds; Bilirubin; Carbon Monoxide; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Deferoxamine; Disulfides; Enzyme Inhibitors; Ethanol; Ferrous Compounds; Glutathione; Heme Oxygenase-1; Hemoglobins; Hepatocytes; Humans; Iron; L-Lactate Dehydrogenase; Liver Diseases, Alcoholic; Malondialdehyde; Organometallic Compounds; Protoporphyrins; Quercetin; Transaminases | 2009 |
Role of iron in the pathogenesis of cysteamine-induced duodenal ulceration in rats.
Topics: Animal Structures; Animals; Cation Transport Proteins; Cimetidine; Colon; Cysteamine; Deferoxamine; Duodenal Ulcer; Duodenum; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Gastric Mucosa; Gene Expression; Ileum; Intestinal Mucosa; Iron; Iron Deficiencies; Iron Regulatory Protein 1; Jejunum; Models, Biological; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Receptors, Transferrin | 2009 |
Infantile iron poisoning: challenges in diagnosis and management.
Topics: Deferoxamine; Diagnosis, Differential; Female; Ferrous Compounds; Humans; Infant, Newborn; Poisoning; Treatment Outcome | 2009 |
Towards the mechanism and comparative effect of diphenyl diselenide, diphenyl ditelluride and ebselen under various pathophysiological conditions in rat's kidney preparation.
Topics: Animals; Antioxidants; Azoles; Benzene Derivatives; Deferoxamine; Ferrous Compounds; Hydrogen-Ion Concentration; Isoindoles; Kidney; Lipid Peroxidation; Male; Organometallic Compounds; Organoselenium Compounds; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Siderophores; Thiobarbituric Acid Reactive Substances | 2009 |
Hydrogen peroxide differentially affects activity in the pre-Bötzinger complex and hippocampus.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Biophysics; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Ferrous Compounds; GABA Antagonists; Hippocampus; Hydrogen Peroxide; In Vitro Techniques; Lipid Peroxidation; Malondialdehyde; Mice; Neurons; Oxidants; Patch-Clamp Techniques; Picrotoxin; Piperazines; Respiratory Center; Siderophores | 2011 |
Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.
Topics: alpha-Tocopherol; Atherosclerosis; Chlorides; Deferoxamine; Ferric Compounds; Ferrous Compounds; Hydrogen-Ion Concentration; Iron Chelating Agents; Lipoproteins, LDL; Lysosomes; Pentetic Acid | 2012 |
Iron autointoxication in a 16-year-old girl: a protective role for hepcidin?
Topics: Acidosis; Adolescent; Antimicrobial Cationic Peptides; Deferoxamine; Female; Ferrous Compounds; Hematinics; Hepcidins; Humans; Hyperglycemia; Iron; Iron Chelating Agents; Suicide, Attempted | 2013 |
Iron status and lipopolysaccharide regulate Ndfip1 by activation of nuclear factor-kappa B.
Topics: Animals; Carrier Proteins; Cation Transport Proteins; Cell Line, Tumor; Deferoxamine; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Intercellular Signaling Peptides and Proteins; Iron; Iron Chelating Agents; Lipopolysaccharides; Membrane Proteins; Mice; Neurons; NF-kappa B; Quaternary Ammonium Compounds | 2013 |
Acute iron intoxication: change in urine color during chelation therapy with deferoxamine.
Topics: Chelation Therapy; Color; Deferoxamine; Female; Ferrous Compounds; Heavy Metal Poisoning; Humans; Iron; Poisoning; Suicide, Attempted; Young Adult | 2014 |
Mefloquine in combination with hemin causes severe damage to adult Schistosoma japonicum in vitro.
Topics: 2,2'-Dipyridyl; Animals; Anthelmintics; Ascorbic Acid; Cysteine; Deferiprone; Deferoxamine; Drug Synergism; Drug Therapy, Combination; Ferric Compounds; Ferrous Compounds; Glutathione; Hemin; Inhibitory Concentration 50; Iron Chelating Agents; Mefloquine; Protoporphyrins; Pyridones; Schistosoma japonicum | 2014 |
Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells.
Topics: Animals; Apoferritins; Benzoates; Cell Death; Cell Line, Tumor; Chlorides; Deferasirox; Deferoxamine; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Iron Chelating Agents; Iron Deficiencies; JNK Mitogen-Activated Protein Kinases; Palmitic Acid; Rats; Receptors, Transferrin; Signal Transduction; Transcription Factor CHOP; Transferrin; Triazoles | 2015 |
The Dark Side of Iron.
Topics: Acidosis; Adolescent; Anemia, Iron-Deficiency; Deferoxamine; Drug Overdose; Female; Ferrous Compounds; Fluid Therapy; Hematinics; Humans; Radiography, Abdominal; Shock; Siderophores; Stomach; Suicide, Attempted; Tablets | 2020 |